Bactroban Nasal — Class II drug recall D-1444-2016
Terminated recall by GlaxoSmithKline, LLC, reported 2016-07-27, distributed nationwide. Penicillin Cross Contamination
| Recall number | D-1444-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | GlaxoSmithKline, LLC, Zebulon, NC, United States |
| Recall initiated | 2016-07-18 |
| Classified | 2016-07-20 |
| Reported by FDA | 2016-07-27 |
| Terminated | 2017-08-09 |
| Distributed | Nationwide (US) |
| Quantity | 153,119 tubes |
| NDC | 00029-1526-11 |
| Lot numbers | C686801, C689267, C692405, C698116, C750793, C750794, C752166, C752805, C754828 |
| Expiration dates | 2016-07-20, 2016-09-20, 2017-11-20 |
Product
Bactroban Nasal, (Mupirocin Calcium Ointment 2%), 1 gram Single Use Tubes, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0029-1526-11.
Reason for recall
Penicillin Cross Contamination
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1444-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.